Advertisement

Topics

Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand, [18F]MK-6240

09:42 EDT 30 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
This week Imanova, a world-leading expert in imaging sciences, has signed an agreement that grants the company the right to manufacture for distribution and on-site use [18F]MK-6240, an early stage investigational Positron Emiss...

Other Sources for this Article

Cerveau Technologies, Inc.
Rick Hiatt, 617-906-2715
RFhiatt@cerveautechnologies.com

NEXT ARTICLE

More From BioPortfolio on "Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand, [18F]MK-6240"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...